IMC Chicago
AZN icon

IMC Chicago’s AstraZeneca AZN Stock Holding History

IMC Chicago’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3M Buy
113,000
+20,250
+22% +$3.9M 0.01% 806
2025
Q4 		$17.1M Buy
92,750
+19,550
+27% +$3.43M 0.01% 920
2025
Q3 		$11.2M Sell
73,200
-10,700
-13% -$1.62M ﹤0.01% 1095
2025
Q2 		$11.7M Sell
83,900
-7,400
-8% -$1.04M 0.01% 952
2025
Q1 		$13.4M Buy
91,300
+29,850
+49% +$4.32M 0.01% 747
2024
Q4 		$8.05M Buy
61,450
+11,550
+23% +$1.62M ﹤0.01% 1019
2024
Q3 		$7.78M Sell
49,900
-11,250
-18% -$1.82M ﹤0.01% 933
2024
Q2 		$9.54M Sell
61,150
-3,050
-5% -$459K 0.01% 806
2024
Q1 		$8.7M Buy
64,200
+34,600
+117% +$4.58M 0.01% 751
2023
Q4 		$3.99M Sell
29,600
-12,100
-29% -$1.57M ﹤0.01% 950
2023
Q3 		$5.65M Sell
41,700
-72,050
-63% -$9.84M 0.01% 711
2023
Q2 		$16.3M Buy
113,750
+72,050
+173% +$10.6M 0.02% 408
2023
Q1 		$5.79M Sell
41,700
-650
-2% -$87.5K 0.01% 613
2022
Q4 		$5.74M Buy
42,350
+13,600
+47% +$1.71M 0.01% 576
2022
Q3 		$3.15M Sell
28,750
-18,750
-39% -$2.38M ﹤0.01% 659
2022
Q2 		$6.28M Buy
47,500
+4,450
+10% +$584K 0.01% 516
2022
Q1 		$5.71M Sell
43,050
-14,950
-26% -$1.79M 0.01% 551
2021
Q4 		$6.76M Sell
58,000
-2,100
-3% -$247K 0.01% 558
2021
Q3 		$7.22M Sell
60,100
-4,550
-7% -$530K 0.01% 559
2021
Q2 		$7.75M Buy
64,650
+11,000
+21% +$1.21M 0.01% 504
2021
Q1 		$5.33M Sell
53,650
-22,550
-30% -$2.27M 0.01% 554
2020
Q4 		$7.62M Buy
76,200
+12,800
+20% +$1.36M 0.01% 460
2020
Q3 		$6.95M Buy
+63,400
New +$7.05M 0.01% 371

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

IMC Chicago's AZN Position: Q4 2025 in Review

IMC Chicago sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 20,753 shares — an estimated $3.64M sold.

IMC Chicago first reported a position in AZN in Q4 2020 and held it in 4 quarters. The position peaked at $3.18M in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • IMC Chicago reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 20,753 AstraZeneca shares in Q4 2025, an estimated $3.64M.
  • IMC Chicago first reported a position in AstraZeneca in Q4 2020 and held it in 4 quarters.
  • IMC Chicago's AstraZeneca position peaked at $3.18M in Q3 2025.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.